Blog - Page 3835 of 5436

ThursdaySep 10, 2009 12:59 pm

Easy Energy, Inc. (ESYE.OB) Announces Purchase Orders Totaling $700,000

Easy Energy, Inc. today announced that it has signed purchase orders with a purchaser/reseller based in the U.S., and with its distributor in the UK and Ireland. The orders are for the company’s YoGen cell phone charger device. Gross sales revenues for these transactions are expected to total $700,000. "This is the launch of our world-wide marketing vision for the Company. We are very pleased with our immediate success and we look forward to executing our world-wide marketing and sales program. We intend to reach many markets in the U.S. and in Europe and across the globe through traditional electronics…

ThursdaySep 10, 2009 11:20 am

Keep Clenergen Corp. (CRGE.OB) on Radar!

Clenergen Corporation is focused on using a proprietary biomass process to generate renewable electricity. The company has identified two fast growing species of tree and applied a proprietary Tree Adaption Process for rapidly increasing the growth rate 30‐40%. This substantial growth rate will enable the production of an economically viable source of feedstock/biomass for creating a renewable source of electricity. The company anticipates the implementation of a 71MW per hour biomass power plant in Tamilnadu, India, which will be phased over a 42 month period. It is expected that by 2010, the power plant will generate 15MW per hour. Utilizing…

ThursdaySep 10, 2009 10:11 am

Protalix BioTherapeutics, Inc. (PLX) Complex Receives FDA’s Orphan Drug Designation

Earlier today, Protalix BioTherapeutics, Inc. announced exciting news regarding its proprietary plant cell, prGCD. The company has received notice from the U.S. Food and Drug Administration that the Office of Orphan Products Development has granted orphan drug designation to prGCD, which contains an expressed recombinant form of glucocerebrosidase (GCD), for the treatment of Gaucher disease. Gaucher disease is a lysosomal storage disorder resulting from a deficiency or mutation of the GCD enzyme. The disease affects the liver, spleen, bone marrow, and in some cases, the central nervous system. Orphan drug designation is granted to drugs that may potentially provide a…

ThursdaySep 10, 2009 10:09 am

Kaman Corp. (KAMN) Awarded $53 Million Helicopter Contract

Kaman Corp. produces and/or markets widely-used products for various commercial firms and the military. The company announced today that the helicopter division of its subsidiary, Kaman Aerospace, has been awarded a five-year contract with a potential value of $53 million to build composite helicopter blade skins and skin core assemblies for Bell Helicopters. President and CEO of Kaman Corporation, Neal J. Keating, spoke about the contract award, “We are delighted by this opportunity to work with Bell Helicopter in producing world-class rotorcraft. This is further evidence of our ability to leverage our OEM (original equipment manufacturer) capabilities in support of…

ThursdaySep 10, 2009 10:07 am

eDOORWAYS Corp. (EDWY.PK) Explains Their Business Revenue Model

eDoorways Corp. envisions itself as a revolutionary web-based consumer problem solving gateway. The company's goal is to completely change the way that consumers and both on-line and off-line businesses find each other by matching consumer needs with businesses that offer the best possible solutions. Chairman and CEO of eDoorways, Gary Kimmons, recently described the company's business revenue model in a nutshell, “eDoorways will provide a host of attractive free services and features to users that will organically build our platform and provide myriad revenue opportunities.” When the company's SOLVE doorway is launched October 1st, consumers will have free access to…

ThursdaySep 10, 2009 10:04 am

OLB Group, Inc. (OLBG.OB) Launches Aggressive Advertising Campaign

OLB Group, Inc. has been gaining a stellar reputation as an innovative e-commerce service provider that offers software products and services designed to help businesses sell products over the internet. Today, the young company announced they will be offering patented derma-cosmetic products from Leorex Ltd. to its clients for marketing to their end users. To coincide with the previously announced joint venture with Leorex, a new website has been launched utilizing the current platform of e-commerce from ShopFast, OLBG's software platform, at http://www.leorexdirect.com/freetrial.aspx. An integral part of the campaign includes free membership to the Platinum Club, which offers discounts of…

ThursdaySep 10, 2009 7:56 am

ImmunoCellular Therapeutics, Ltd. (IMUC.OB) Enters into Research and License Option Agreement with Roche Group

ImmunoCellular Therapeutics, Ltd., a Los Angeles-based clinical-stage company that is developing immune based therapies for the treatment of brain and other cancers, recently announced that the company has entered into a research and license option agreement regarding its ICT-69 antibody with Roche Group (SWX: ROG.VX; RO.S, OTCQX: RHHBY). As one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics, Roche Group will pay royalties to ImmunoCellular Therapeutics based on the company’s worldwide sales of ICT-69 products. Under the terms of the agreement, ImmunoCellular Therapeutics will license to Roche the rights to investigate the potential of…

ThursdaySep 10, 2009 7:53 am

China’s Environment and Coal

China has an environmental problem which the government has been aware of for years. Polluters have been able to dump massive amounts of toxic wastes into China's air and water for many years with no repercussions because the mandate from Beijing was for economic growth at all costs. But that is all changing. China now has an environmental movement among its people which is in its infancy, but growing quickly. The interesting facet of China's nascent environmental movement is that the central government in Beijing is actually listening to the environmentalists, at least to a certain extent. They are cracking…

WednesdaySep 09, 2009 1:24 pm

Green Planet Bioengineering CO. LTD. (GPLB.OB) Launches Two New Natural Extracts into the Health Supplement Market

Green Planet Bioengineering CO. LTD., a subsidiary of ONE Holdings Corp. (ONEZ.OB), focuses on research and development, production and sale of various extracts that can be used for health supplements and organic agricultural products. The company today issued a press release introducing two natural extracts, Resveratrol and 5-HTP, which are expected to generate about $1.8 million in revenue for the company in the third quarter. Green Planet has teamed with Fujian Traditional Chinese Medical College to create and execute a marketing campaign for Resveratrol and 5-HTP. The new health supplements have contributed $1 million in revenue since they were originally…

WednesdaySep 09, 2009 12:55 pm

Butler National Corporation (BUKS) Reports Solid Quarter

Butler National Corp. reported net income of $718,000 in its first quarter of fiscal 2010 (ending July 31, 2009). This was up 126% over the same period in 2008. Revenues were $6.06 million, up 17% year-over-year. Butler National Corporation also reported a backlog of $10.8 million as of 8/28/2009. The Avionics segment saw the biggest increase in revenues, which totaled $2.3 million, up 161% on a year-over-year basis. Operating profit in this segment, which manufactures and repairs airborne switching units for Boeing and other aircraft, reached $946,000. Butler National Corporation is an Aerospace company that provides products and services for…

Site Search

Company Search